Pharmalane Exports

Xtandi 40 mg Capsules by Intas Pharmaceuticals are prescribed for the treatment of prostate cancer. Each pack contains 2 capsules designed to inhibit androgen receptors, slowing cancer cell growth. Suitable for adult patients, these capsules should be taken as directed by a healthcare professional.

Lucicapiva Capivasertib Tablets, 200 mg, are a targeted therapy designed to inhibit specific enzymes involved in cancer cell growth and survival. Ideal for patients requiring precision treatment, these tablets offer a potent option for managing certain types of cancer. Always consult with a healthcare professional before use.

Enasidenib 50mg Tablet is a prescription medication used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. It works by inhibiting the mutated IDH2 enzyme, helping to restore normal blood cell production. Suitable for adult patients, this oral tablet is taken once daily, with or without food, as directed by a healthcare professional.

Braftovi Encorafenib 75mg capsules are a targeted cancer therapy designed to inhibit the BRAF V600E mutation in melanoma patients. These capsules work by blocking the abnormal BRAF protein, slowing or stopping cancer cell growth. Suitable for use in combination with other medications, Braftovi offers a personalized treatment approach for improved patient outcomes.

Abiraterone Acetate 250 mg Tablets are a prescription medication used to treat metastatic castration-resistant prostate cancer. They work by inhibiting the production of androgens, which fuel the growth of prostate cancer cells. Typically administered alongside prednisone, these tablets help manage and slow the progression of the disease.

Acalabrutinib 100 mg is a prescription medication used to treat certain types of blood cancers, including mantle cell lymphoma and chronic lymphocytic leukemia. It works as a Bruton's tyrosine kinase (BTK) inhibitor, blocking the enzyme that promotes cancer cell growth. This oral capsule is designed to be taken twice daily, offering a targeted approach to disrupt cancer cell proliferation while minimizing impact on healthy cells.

Hydroxyurea Capsule 500mg is an allopathic medication used to treat certain types of cancer, such as chronic myeloid leukemia and ovarian cancer, as well as sickle cell anemia. It works by inhibiting the growth of cancer cells and reducing painful sickle cell crises. Administered orally, it is typically prescribed by a healthcare professional as part of a comprehensive treatment plan.

Abiraterone Acetate Tablets 250 mg are a prescription medication used to treat metastatic castration-resistant prostate cancer. They work by inhibiting the production of androgens, which fuel the growth of prostate cancer cells. Typically administered alongside prednisone, these tablets help manage the progression of the disease and improve patient outcomes.

Acalabrutinib Capsules 100 mg are a prescription medication used to treat certain types of blood cancers, including mantle cell lymphoma and chronic lymphocytic leukemia. As a selective Bruton tyrosine kinase (BTK) inhibitor, Acalabrutinib works by blocking the enzyme that promotes cancer cell growth, helping to slow or stop the progression of the disease. These capsules are designed for oral administration and should be taken as directed by a healthcare professional.

150mg Olaparib Bracanat Tablets are a targeted cancer therapy designed to inhibit the growth of cancer cells in patients with specific genetic mutations. These tablets are primarily used for the treatment of certain types of ovarian, breast, pancreatic, and prostate cancers. Olaparib works by blocking the enzyme PARP, which helps repair damaged DNA in cancer cells, thereby preventing their proliferation. Suitable for patients with BRCA1 or BRCA2 mutations, these tablets offer a personalized approach to cancer treatment.

Abemaciclib 150 mg tablets are a prescription medication used to treat certain types of breast cancer. As a CDK4/6 inhibitor, Abemaciclib works by interfering with cancer cell growth and division. It is typically prescribed in combination with hormone therapy for advanced or metastatic breast cancer in patients with HR-positive, HER2-negative status. Always follow your healthcare provider's instructions for dosage and administration.

Survanta (beractant) is a sterile, non-pyrogenic pulmonary surfactant intended for intratracheal use. It is used to prevent and treat Respiratory Distress Syndrome (RDS) in premature infants by reducing surface tension in the lungs, improving lung compliance, and stabilizing alveoli. Survanta is administered via endotracheal tube and is designed to mimic the natural surfactant in the lungs, enhancing breathing and oxygenation in newborns.